Stock Overview

Day One Biopharmaceuticals Inc. (DAWN) is a leading Manufacturing company in the Pharmaceutical Preparation Manufacturing industry, currently trading at $7.44 with a market capitalization of $750.83 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating concerning quality fundamentals with a MarketXLS quality score of 39.

Today's trading session shows DAWN with a volume of 3.62 million shares. The stock opened up 0.43% from yesterday's close of $7.04. Current analyst estimates project earnings of $-1.19 per share for this year, with next year targeting $-0.79.

DAWN demonstrates very strong technical momentum based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.

Key investment considerations for DAWN include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 230.1%. The stock shows fair valuation metrics based on valuation analysis.

Analysis generated on November 3, 2025 at 07:25 AM